The potential of these new disease-modifying treatments represents a defining moment for Alzheimer’s disease. However, currently, health care systems across the UK, are not ready to deliver breakthrough treatments if they become available. Currently, too many people living with dementia are doing so without a diagnosis. This means they can’t access the vital care and support they deserve and will not be able to receive new treatments for which they may be eligible, if those treatments are approved.
For more details on our calls, visit our webpage here.